Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer.
about
Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study.Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy.Androgen Receptor Signaling in Salivary Gland Cancer.The oncological outcome and validation of Japan Cancer of the Prostate Risk Assessment score among men treated with primary androgen-deprivation therapy.Impact of early changes in serum biomarkers following androgen deprivation therapy on clinical outcomes in metastatic hormone-sensitive prostate cancer.
P2860
Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 June 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predicting response to hormona ...... ve metastatic prostate cancer.
@en
Predicting response to hormona ...... ve metastatic prostate cancer.
@nl
type
label
Predicting response to hormona ...... ve metastatic prostate cancer.
@en
Predicting response to hormona ...... ve metastatic prostate cancer.
@nl
prefLabel
Predicting response to hormona ...... ve metastatic prostate cancer.
@en
Predicting response to hormona ...... ve metastatic prostate cancer.
@nl
P2860
P1476
Predicting response to hormona ...... ve metastatic prostate cancer.
@en
P2093
Maha Hussain
Petros D Grivas
P2860
P356
10.1016/J.CRITREVONC.2012.05.003
P577
2012-06-16T00:00:00Z